MiR-542-3p inhibits the growth and invasion of colorectal cancer cells through targeted regulation of cortactin

International Journal of Molecular Medicine

Volumn 37, Issue 4, 2016, Pages 1112-1118

  Long, Hao Cheng ^a   Gao, Xia ^a   Lei, Chang Jiang ^a   Zhu, Bin ^a   Li, Lei ^a   Zeng, Cheng ^a   Huang, Jian Bin ^a   Feng, Jia Rui ^a  

^a The Fifth Hospital of Wuhan   (China)

Author keywords

Colorectal cancer; Cortactin; CTTN; MicroRNA; MiR 542 3p

Indexed keywords

CORTACTIN; MICRORNA; MICRORNA 542 3P; UNCLASSIFIED DRUG; CTTN PROTEIN, HUMAN; MIRN542 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; COLORECTAL CANCER; CONTROLLED STUDY; CTTN GENE; DOWN REGULATION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; CELL MOTION; CELL PROLIFERATION; COLON; COLORECTAL TUMOR; GENETICS; METABOLISM; PATHOLOGY; RECTUM; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; CORTACTIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; RECTUM; TRANSFECTION;

EID: 84960532416     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2505     Document Type: Article

References (35)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. Li M and Gu J: Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol 11: 4685-4688, 2005.
3. Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, Chen L, Varella-Garcia M, Sacks PG, Frederick B, et al: Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 66: 8017-8025, 2006.
4. Schuuring E: The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene 159: 83-96, 1995.
5. Lee YY, Yu CP, Lin CK, Nieh S, Hsu KF, Chiang H and Jin JS: Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters. Dis Markers 26: 9-18, 2009.
6. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai Y, Zhang X, Sun YT, Zhan QM, Wu M and Wang MR: Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699, 2006.
7. Timpson P, Wilson AS, Lehrbach GM, Sutherland RL, Musgrove EA and Daly RJ: Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. Cancer Res 67: 9304-9314, 2007.
8. Buday L and Downward J: Roles of cortactin in tumor pathogenesis. Biochim Biophys Acta 1775: 263-273, 2007.
9. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A, Ohta T, Asaka M and Hirohashi S: Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 41: 629-636, 2004.
10. Weaver AM: Cortactin in tumor invasiveness. Cancer Lett 265: 157-166, 2008.
11. van Rossum AG, Moolenaar WH and Schuuring E: Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp Cell Res 312: 1658-1670, 2006.
12. Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A and Buccione R: Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 121: 369-378, 2008.
13. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
14. Hashimoto Y, Akiyama Y and Yuasa Y: Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One 8: e62589, 2013.
15. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et al: Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33: 2391-2397, 2012.
16. Zhang GJ, Xiao HX, Tian HP, Liu ZL, Xia SS and Zhou T: Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. Int J Mol Med 31: 1375-1380, 2013.
17. Chiang Y, Song Y, Wang Z, Liu Z, Gao P, Liang J, Zhu J, Xing C and Xu H: microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer. Exp Ther Med 3: 560-566, 2012.
18. Goel A and Boland CR: Recent insights into the pathogenesis of colorectal cancer. Curr Opin Gastroenterol 26: 47-52, 2010.
19. Shibuya H, Iinuma H, Shimada R, Horiuchi A and Watanabe T: Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 79: 313-320, 2010.
20. Althoff K, Lindner S, Odersky A, Mestdagh P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S, Speleman F, et al: miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int J Cancer 136: 1308-1320, 2015.
21. Yoon S, Choi YC, Lee S, Jeong Y, Yoon J and Baek K: Induction of growth arrest by miR-542-3p that targets survivin. FEBS Lett 584: 4048-4052, 2010.
22. Condeelis J and Segall JE: Intravital imaging of cell movement in tumours. Nat Rev Cancer 3: 921-930, 2003.
23. Kedrin D, Wyckoff J, Sahai E, Condeelis J and Segall JE: Imaging tumor cell movement in vivo. Curr Protoc Cell Biol Chapter 19: Unit 19.7, 2007. doi: 10.1002/0471143030.cb1907s35.
24. Kedrin D, van Rheenen J, Hernandez L, Condeelis J and Segall JE: Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 12: 143-152, 2007.
25. Pollard TD, Blanchoin L and Mullins RD: Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu Rev Biophys Biomol Struct 29: 545-576, 2000.
26. Uruno T, Liu J, Zhang P, Fan YX, Egile C, Li R, Mueller SC and Zhan X: Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol 3: 259-266, 2001.
27. Hirakawa H, Shibata K and Nakayama T: Localization of cortactin is associated with colorectal cancer development. Int J Oncol 35: 1271-1276, 2009.
28. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu, Dyrskjøt L, Wiuf C, Sørensen FJ, Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
29. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R and Vyzula R: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007.
30. Zhang L, Liu T, Huang Y and Liu J: microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein. Int J Mol Med 28: 381-388, 2011.
31. Hong CC, Chen PS, Chiou J, Chiu CF, Yang CY, Hsiao M, Chang YW, Yu YH, Hung MC, Hsu NW, et al: miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression. Cancer Res 74: 6280-6290, 2014.
32. Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y, Chen YQ and Hong SJ: Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol 7: 6, 2014.
33. Wang Y, Huang JW, Castella M, Huntsman DG and Taniguchi T: p53 is positively regulated by miR-542-3p. Cancer Res 74: 3218-3227, 2014.
34. He T, Qi F, Jia L, Wang S, Song N, Guo L, Fu Y and Luo Y: MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2. J Pathol 232: 499-508, 2014.
35. Shen X, Si Y, Yang Z, Wang Q, Yuan J and Zhang X: MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1. Med Oncol 32: 361, 2015.